ArticleLasers in medical science2026
A simulation-based optical safety framework for dermatologic laser wavelength selection across Fitzpatrick skin phototypes.
Article in Lasers in medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Laser wavelength selection in dermatology remains challenging across diverse skin phototypes, where inappropriate choice may increase the risk of epidermal injury. This study develops a simulation-based optical safety framework to support wavelength selection by quantifying phototype-dependent epidermal energy deposition and dermal-to-epidermal energy balance. A Monte Carlo light-transport model was used to simulate photon propagation in a three-layer skin model across Fitzpatrick skin types I-VI. Four commonly used dermatologic wavelengths (532, 755, 808 and 1064 nm) were evaluated. Epidermal energy deposition was quantified using the Epidermal Thermal Risk Index (ETRI), and dermal-to-epidermal energy balance was quantified using the Benefit-Risk Ratio (BRR). ETRI categories were defined as heuristic interpretive ranges. A composite score combining safety and energy-balance components was computed and tested across multiple weighting schemes via sensitivity analysis. Shorter wavelengths produced markedly higher epidermal energy deposition, particularly in higher phototypes. At 532 nm, ETRI rose monotonically with melanin content, indicating elevated epidermal optical burden. In contrast, 1064 nm maintained the lowest ETRI values across all phototypes. Across five tested weighting schemes, including extreme configurations, 1064 nm consistently demonstrated the highest composite score in every phototype (Spearman ρ = 1.00 against the equal-weight baseline), supporting robustness of the framework. This study presents a simulation-based optical safety framework that translates wavelength-dependent energy deposition into an interpretable structure for laser wavelength selection. Within the assumptions of the model, longer wavelengths - and 1064 nm in particular - demonstrate the most favorable epidermal safety profile and dermal-to-epidermal energy balance across higher phototypes. The framework is intended as relative optical safety guidance and must be integrated with treatment indication, target chromophore, fluence, pulse duration, epidermal cooling, device-specific settings and operator experience in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.